Related Posts
Lonza Issues Exclusive, Target-Specific License to Antharis Therapeutics to Advance Next-Generation Dual Payload ADCs for Gastrointestinal Cancers
BASEL, Switzerland and SAN DIEGO, June 15, 2026 /PRNewswire/ — Lonza and Antharis...
Daniel Yazbeck is featured in March 2021 on Vice News
Daniel Yazbeck is featured in March 2021 on Vice News...
MED-CANN World Summit 2020 Keynote Presentation
MED-CANN World Summit 2020 | Keynote Presentation by Daniel Yazbeck...
One Comment
Comments are closed.

Hi, this is a comment.
To get started with moderating, editing, and deleting comments, please visit the Comments screen in the dashboard.
Commenter avatars come from Gravatar.